Skip to main content
Erschienen in: CME 12/2015

22.12.2015 | CME Fortbildung

Diabetes, Prädiabetes und kardiovaskuläres Risiko

verfasst von: B. Stratmann, Prof. Dr. Dr. h.c. D. Tschoepe

Erschienen in: CME | Ausgabe 12/2015

Einloggen, um Zugang zu erhalten

Zusammenfassung

Herz-Kreislauf-Erkrankungen erhöhen die Morbidität und Mortalität in der Gesellschaft. Diabetes mellitus gilt als Risikofaktor für eine koronare Herzkrankheit (KHK), Herzinsuffizienz und für vaskuläre Ereignisse. Die Mehrzahl der Patienten weist eine Risikokonstellation aus Hypertonie, Dyslipoproteinämie und (prä-)diabetischer Stoffwechsellage auf, die eine exponentielle Risikoerhöhung bedingt. Aus der Perspektive der Organerkrankung zeigen zwei Drittel der Patienten mit symptomatischer KHK Glukosestoffwechselstörungen. Umgekehrt haben bei Manifestation eines Myokardinfarkts 25–28 % der Patienten keine Glukosestoffwechselstörung. Frauen sind häufiger betroffen und weisen eine schlechtere Prognose auf, wenn die Diabetesdiagnose und ein Gefäßereignis zusammenfallen. Diabetes mellitus ist signifikant häufiger mit Vorhofflimmern und dem Risiko einer Herzinsuffizienz assoziiert. Mit der unzureichenden Blutzuckereinstellung steigt das Risiko für vaskuläre Ereignisse überproportional an.
Literatur
[1]
Zurück zum Zitat Ryden L, Grant PJ, Anker SD et al (2013) ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 34:3035–3087PubMedCrossRef Ryden L, Grant PJ, Anker SD et al (2013) ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 34:3035–3087PubMedCrossRef
[2]
Zurück zum Zitat Taubert G, Winkelmann BR, Schleiffer T et al (2003) Prevalence, predictors, and consequences of unrecognized diabetes mellitus in 3266 patients scheduled for coronary angiography. Am Heart J 145:285–291PubMedCrossRef Taubert G, Winkelmann BR, Schleiffer T et al (2003) Prevalence, predictors, and consequences of unrecognized diabetes mellitus in 3266 patients scheduled for coronary angiography. Am Heart J 145:285–291PubMedCrossRef
[3]
Zurück zum Zitat Doerr R, Hoffmann U, Otter W et al (2011) Oral glucose tolerance test and HbA(1)c for diagnosis of diabetes in patients undergoing coronary angiography: [corrected] the Silent Diabetes Study. Diabetologia 54:2923–2930PubMedCrossRef Doerr R, Hoffmann U, Otter W et al (2011) Oral glucose tolerance test and HbA(1)c for diagnosis of diabetes in patients undergoing coronary angiography: [corrected] the Silent Diabetes Study. Diabetologia 54:2923–2930PubMedCrossRef
[4]
Zurück zum Zitat Gitt A (2010) Hohe Prävalenz des unbekannten Diabetes bei Patienten mit akutem Myokardinfarkt in Deutschland — Ergebnisse des SWEETHEART-Registers. Diab Stoffw Herz 19:383 Gitt A (2010) Hohe Prävalenz des unbekannten Diabetes bei Patienten mit akutem Myokardinfarkt in Deutschland — Ergebnisse des SWEETHEART-Registers. Diab Stoffw Herz 19:383
[5]
Zurück zum Zitat Tschoepe D, Towae F, Papp A et al (2012) High 3-year-mortality rates in females with newly diagnosed diabetes after acute STEMI and NSTEMI: results of the SWEETHEART registry. Diabetologia 55 Tschoepe D, Towae F, Papp A et al (2012) High 3-year-mortality rates in females with newly diagnosed diabetes after acute STEMI and NSTEMI: results of the SWEETHEART registry. Diabetologia 55
[6]
Zurück zum Zitat Haffner SM, Lehto S, Ronnemaa T et al (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234PubMedCrossRef Haffner SM, Lehto S, Ronnemaa T et al (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234PubMedCrossRef
[7]
Zurück zum Zitat Behrens M, Doerr R, Eckert S et al (2014) Diabetes mellitus und Herz. Diabetol Stoffw 9:S120–S124 Behrens M, Doerr R, Eckert S et al (2014) Diabetes mellitus und Herz. Diabetol Stoffw 9:S120–S124
[8]
Zurück zum Zitat Genders TS, Steyerberg EW, Alkadhi H et al (2011) A clinical prediction rule for the diagnosis of coronary artery disease: validation, updating, and extension. Eur Heart J 32:1316–1330PubMedCrossRef Genders TS, Steyerberg EW, Alkadhi H et al (2011) A clinical prediction rule for the diagnosis of coronary artery disease: validation, updating, and extension. Eur Heart J 32:1316–1330PubMedCrossRef
[10]
Zurück zum Zitat Pryor DB, Bruce RA, Chaitman BR et al (1989) Task force I: determination of prognosis in patients with ischemic heart disease. J Am Coll Cardiol 14:1016–1025PubMedCrossRef Pryor DB, Bruce RA, Chaitman BR et al (1989) Task force I: determination of prognosis in patients with ischemic heart disease. J Am Coll Cardiol 14:1016–1025PubMedCrossRef
[11]
Zurück zum Zitat Young LH, Wackers FJ, Chyun DA et al (2009) Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA 301:1547–1555PubMedPubMedCentralCrossRef Young LH, Wackers FJ, Chyun DA et al (2009) Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA 301:1547–1555PubMedPubMedCentralCrossRef
[12]
Zurück zum Zitat Wackers FJ, Young LH (2009) Lessons learned from the detection of ischemia in asymptomatic diabetics (DIAD) study. J Nucl Cardiol 16:855–859PubMedCrossRef Wackers FJ, Young LH (2009) Lessons learned from the detection of ischemia in asymptomatic diabetics (DIAD) study. J Nucl Cardiol 16:855–859PubMedCrossRef
[13]
Zurück zum Zitat Muhlestein JB, Lappe DL, Lima JA et al (2014) Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial. JAMA 312:2234–2243PubMedCrossRef Muhlestein JB, Lappe DL, Lima JA et al (2014) Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial. JAMA 312:2234–2243PubMedCrossRef
[14]
Zurück zum Zitat Ryden L, Standl E, Bartnik M et al (2007) Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death — executive summary. Rev Port Cardiol 26:1213–1274PubMed Ryden L, Standl E, Bartnik M et al (2007) Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death — executive summary. Rev Port Cardiol 26:1213–1274PubMed
[15]
Zurück zum Zitat Poulsen MK, Henriksen JE, Dahl J et al (2010) Left ventricular diastolic function in type 2 diabetes mellitus: prevalence and association with myocardial and vascular disease. Circ Cardiovasc Imaging 3:24–31PubMedCrossRef Poulsen MK, Henriksen JE, Dahl J et al (2010) Left ventricular diastolic function in type 2 diabetes mellitus: prevalence and association with myocardial and vascular disease. Circ Cardiovasc Imaging 3:24–31PubMedCrossRef
[16]
Zurück zum Zitat Reaven PD, Moritz TE, Schwenke DC et al (2009) Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis. Diabetes 58:2642–2648PubMedPubMedCentralCrossRef Reaven PD, Moritz TE, Schwenke DC et al (2009) Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis. Diabetes 58:2642–2648PubMedPubMedCentralCrossRef
[17]
Zurück zum Zitat Farkouh ME, Domanski M, Sleeper LA et al (2012) Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 367:2375–2384PubMedCrossRef Farkouh ME, Domanski M, Sleeper LA et al (2012) Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 367:2375–2384PubMedCrossRef
[18]
Zurück zum Zitat Kappetein AP, Head SJ, Morice MC et al (2013) Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. Eur J Cardiothorac Surg 43:1006–1013PubMedCrossRef Kappetein AP, Head SJ, Morice MC et al (2013) Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. Eur J Cardiothorac Surg 43:1006–1013PubMedCrossRef
[19]
Zurück zum Zitat Mohr FW, Morice MC, Kappetein AP et al (2013) Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 381:629–638PubMedCrossRef Mohr FW, Morice MC, Kappetein AP et al (2013) Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 381:629–638PubMedCrossRef
[20]
Zurück zum Zitat Halle M, Gitt AK, Hanefeld M et al (2012) Diabetes and heart failure: a practically oriented critical appraisal. Dtsch Med Wochenschr 137:437–441PubMedCrossRef Halle M, Gitt AK, Hanefeld M et al (2012) Diabetes and heart failure: a practically oriented critical appraisal. Dtsch Med Wochenschr 137:437–441PubMedCrossRef
[22]
Zurück zum Zitat Iribarren C, Karter AJ, Go AS et al (2001) Glycemic control and heart failure among adult patients with diabetes. Circulation 103:2668–2673PubMedCrossRef Iribarren C, Karter AJ, Go AS et al (2001) Glycemic control and heart failure among adult patients with diabetes. Circulation 103:2668–2673PubMedCrossRef
[23]
Zurück zum Zitat Stratton IM, Adler AI, Neil HA et al (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405–412PubMedPubMedCentralCrossRef Stratton IM, Adler AI, Neil HA et al (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405–412PubMedPubMedCentralCrossRef
[24]
Zurück zum Zitat Gustafsson I, Brendorp B, Seibaek M et al (2004) Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure. J Am Coll Cardiol 43:771–777PubMedCrossRef Gustafsson I, Brendorp B, Seibaek M et al (2004) Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure. J Am Coll Cardiol 43:771–777PubMedCrossRef
[25]
[26]
Zurück zum Zitat Huxley RR, Filion KB, Konety S, Alonso A (2011) Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation. Am J Cardiol 108:56–62PubMedPubMedCentralCrossRef Huxley RR, Filion KB, Konety S, Alonso A (2011) Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation. Am J Cardiol 108:56–62PubMedPubMedCentralCrossRef
[27]
Zurück zum Zitat Du X, Ninomiya T, Galan B de et al (2009) Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. Eur Heart J 30:1128–1135PubMedCrossRef Du X, Ninomiya T, Galan B de et al (2009) Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. Eur Heart J 30:1128–1135PubMedCrossRef
[28]
Zurück zum Zitat Huxley RR, Alonso A, Lopez FL et al (2012) Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study. Heart 98:133–138PubMedPubMedCentralCrossRef Huxley RR, Alonso A, Lopez FL et al (2012) Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study. Heart 98:133–138PubMedPubMedCentralCrossRef
[29]
Zurück zum Zitat Camm AJ, Kirchhof P, Lip GY et al (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 12:1360–1420PubMedCrossRef Camm AJ, Kirchhof P, Lip GY et al (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 12:1360–1420PubMedCrossRef
[30]
Metadaten
Titel
Diabetes, Prädiabetes und kardiovaskuläres Risiko
verfasst von
B. Stratmann
Prof. Dr. Dr. h.c. D. Tschoepe
Publikationsdatum
22.12.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
CME / Ausgabe 12/2015
Print ISSN: 1614-371X
Elektronische ISSN: 1614-3744
DOI
https://doi.org/10.1007/s11298-015-1225-9

Weitere Artikel der Ausgabe 12/2015

CME 12/2015 Zur Ausgabe

Leitlinien kompakt für die Allgemeinmedizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Facharzt-Training Allgemeinmedizin

Die ideale Vorbereitung zur anstehenden Prüfung mit den ersten 24 von 100 klinischen Fallbeispielen verschiedener Themenfelder

Mehr erfahren

Update Allgemeinmedizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.